Acusphere Report issue

For profit Phase 3
Founded: Lexington MA United States (1993)
Status: Defunct (2004)

Organization Overview

First Clinical Trial
2004
NCT00156780
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

perfluorobutane (Sonazoid) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 3)

Coronary Disease (Phase 3)

Heart Failure (Phase 1)

Lung Diseases (Phase 1)

Lung Diseases, Obstructive (Phase 1)

Myocardial Ischemia (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1